← SynDRA
ML-193
SynDRA canonical compound SYN0062921 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GPR55 |
|---|
| Mechanism of action | G protein-coupled receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- ML193
- RefChem:1089767
- ML 193
- MLS000862518
- SMR000300559
- CYT387 hydrochloride
- Momelotinib hydrochloride
- MLS003183099
- GTPL9967
- orb1306094
- SCHEMBL29636260
- BDBM50459
- C28H25N5O4S
- CHEBI:92484
- cid_1261822
- EX-A9793A
- GLXC-02605
- HMS2626M05
- NDB12180
- MFCD05999971
- STK461208
- AKOS003360258
- NCGC00370745-03
- AS-16669
- DA-75597
- HY-110125
- CS-0032977
- ST50900216
- E78757
- MLS-0269911.0001
- T22103
- F867133
- N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide
Look up ML-193 in the interactive SynDRA portal →